(15)malignant lymphoma
TRANSCRIPT
-
8/13/2019 (15)Malignant Lymphoma
1/29
MALIGNANT LYMPHOMA
NI PUTU EKAWATI
-
8/13/2019 (15)Malignant Lymphoma
2/29
Lnn Distribution
-
8/13/2019 (15)Malignant Lymphoma
3/29
Normal Histology
-
8/13/2019 (15)Malignant Lymphoma
4/29
General Disorders
Reactive
Proliferations of
White cells andNodes
Acute Nonspesific
Lympadenitis
Chronic NonspesificLympadenitis
Spesific
lympadenitis
NeoplasticProliferations ofWhite Cells Lymphoid neoplasm
Myeloid NeoplasmAML, MDS, MPD
Langerhans cell
Neoplasm
-
8/13/2019 (15)Malignant Lymphoma
5/29
Malignant Lymphoma
Malignant counterpart of normal
lymphocytes
-
8/13/2019 (15)Malignant Lymphoma
6/29
Lymphoma Vs Leukemia
Leukemia : lymphoid neoplasm presentwith widespread involv. of the BM, usuallyaccompanied by the presences of large
numbers of tumor cells in peripheral blood Lymphoma : proliferations arising as
discrete tissue masses.
-
8/13/2019 (15)Malignant Lymphoma
7/29
Etiological and Pathogenetic factors
Chr translocation and oncogenes
Inherited genetic factor
Viruses
HTLV 1, EBV
Enviromental agents
H pylori
Gluten sensitive enteropathy
Iatrogenic
Radiotherapy
Chemotherapy
-
8/13/2019 (15)Malignant Lymphoma
8/29
WHO Classification : Reflection of the
complexity of lymphoid differentiation
Tumor biology
Histomorphology
Immunophenotype
Molecular genetics
Purpose
Ordering Prognostication
Treatment categories
-
8/13/2019 (15)Malignant Lymphoma
9/29
WHO Classification
Lineage differentiation (B,T,NK)
Stage of maturation
Precursor B/T cell
Mature B/T cell
Localization (nodal Vs MALT, skin, spleen)
Molecular (Bcl1, Bcl2, Myc, ALK etc)
-
8/13/2019 (15)Malignant Lymphoma
10/29
WHO Classification
B Cell neoplasm Precursor B cell neoplasm
Mature B cell neoplasm CLL/SLL
Prolymphocytic leukemia
Lymphoplasmacytic lymphoma
Spleenic marginal zone lymphoma Hairy cell leukemia
Plasma cell myeloma
Extraosseus plasmacytoma
Marginal zone leukemia extranodal (MALT)
Marginal zone leukemia Nodal
Follicular lymphoma
Mantle cell lymphoma
Diffuse large B cell lymphoma(var mediastinal)
Burkit lymphoma
Intravascular and primary effusion lymphoma
-
8/13/2019 (15)Malignant Lymphoma
11/29
-
8/13/2019 (15)Malignant Lymphoma
12/29
-
8/13/2019 (15)Malignant Lymphoma
13/29
-
8/13/2019 (15)Malignant Lymphoma
14/29
WHO Classification
T Cell and NK Neoplasm
Precursor T/NK cell neoplasm
Mature T/NK cell neoplasm Leucemic / disseminated
T-cell prolymphocytic leukemia
Cutaneus Mycosis funguides/Sezary syndrome
Primary cutaneus anaplastic large cell lymphoma
Other extranodal NK/T cell lymphoma, nasal type Hepatosleenic T-cell lymphoma
NodalAngioimunoblastic lymphoma
Anaplastic large cell lymphoma
-
8/13/2019 (15)Malignant Lymphoma
15/29
-
8/13/2019 (15)Malignant Lymphoma
16/29
Frequent feature of mature T/NK cell
lymphoma
Broad cytologic spectrum
Disease definition is heavily dependentupon clinical features, not morphology
Infrequent lymph node involvement
Frequent spread to other extranodal sites
Cytotoxic T cell or NK cell phenotype
Frequent apoptosis and/or necrosis
-
8/13/2019 (15)Malignant Lymphoma
17/29
WHO Classification
Hodgkin lymphoma
Nodular lymphocyte predominant HD
Classical HD
Nodular sclerosis HD
Lymphocyte rich classical HD
Mixed cellularity classical HD
Lymphocyte depleted classical HD
-
8/13/2019 (15)Malignant Lymphoma
18/29
HODGKIN LYMPHOMA
Clinically, spread in contiguous fashion
Histologically:
Reed-sternberg cells
Inflammatory cells
RSC derived from B cell of germinal centre
Response to specific types of therapy
-
8/13/2019 (15)Malignant Lymphoma
19/29
Clinical differences HL x NHL
HL
Localized to a single
axial group of nodes
Spread by contiguity Mesenteric &
Waldeyer ring rarely
involved
Extranodal uncommon
NHL
Multiple pheriperal
nodes
Non contiguous Commonly involved
Common
-
8/13/2019 (15)Malignant Lymphoma
20/29
-
8/13/2019 (15)Malignant Lymphoma
21/29
-
8/13/2019 (15)Malignant Lymphoma
22/29
Ann Arbor staging classification
Stage I : involvement of single lymph noderegion or lymphoid structure
Stage II : involvement of two or more lymph
nodes regions on the same side of diaphragm Stage III : involvement of lymph node regions or
structures on both sides of diaphragm
Stage IV : involvement of extranodal site(s)
-
8/13/2019 (15)Malignant Lymphoma
23/29
Grouping Lymphoma by
Clinical Behavior
Lymphoma that are indolent (slow
growing) but usually incurable
CLL/SLL
Follicular lymphoma
MALT lymphoma
-
8/13/2019 (15)Malignant Lymphoma
24/29
Lymphoma that are fairly aggressive if
untreated but may be cured with
appropriate therapy
Hodgkin disease
Follicular lymphoma, large cell type
Diffuse large B cell lymphoma
-
8/13/2019 (15)Malignant Lymphoma
25/29
-
8/13/2019 (15)Malignant Lymphoma
26/29
CD 20 (IHK)
-
8/13/2019 (15)Malignant Lymphoma
27/29
MF
-
8/13/2019 (15)Malignant Lymphoma
28/29
MF
-
8/13/2019 (15)Malignant Lymphoma
29/29